002755 Beijing Aosaikang Pharmaceutical
- 13.80
- +0.28+2.07%
Beijing Aosaikang Pharmaceutical News
Osecon: Report for the third quarter of 2024
Osecon: Announcement of Supervisory Board Resolutions
Osecon: Announcement of Board Resolutions
Osecon: Announcement on Subsidiary Nelatinib Maleate Tablets Obtaining a Drug Registration Certificate
Osecon: Announcement on capital increase for holding subsidiaries
Osecon: Announcement of Resolutions of the 15th Meeting of the 6th Board of Directors
Osecon: Semi-Annual Report Board Resolution Announcement
Osecon: Half-year summary table of non-operating capital usage and other related capital transactions
Osecon: 2024 Semi-Annual Report
Osekon: Announcement of Supervisory Board Resolutions in the Semi-Annual Report
Osecon: 2024 semi-annual financial report
Osecon: 2024 Semi-Annual Report Summary
Beijing Aosaikang Pharmaceutical: Announcement regarding the acceptance of the application for the listing permit of the subsidiary's Erlotinib tablets.
Beijing Aosaikang Pharmaceutical: 2024 Interim Performance Forecast
Beijing Aosaikang Pharmaceutical: Announcement regarding subsidiary's pharmaceutical registration certificate for injection of Fosaprepitant Dimeglumine.
Beijing Aosaikang Pharmaceutical: Legal Opinion on the 2023 Annual General Meeting of Shareholders of Beijing Aosaikang Pharmaceutical Co., Ltd.
Beijing Aosaikang Pharmaceutical: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Beijing Aosaikang Pharmaceutical: Announcement on the subsidiary obtaining a drug registration certificate for injectable isaconazole sulfate
Beijing Aosaikang Pharmaceutical: Verification Report on the 2023 Operating Income Deduction Status Table
Beijing Aosaikang Pharmaceutical: 2024 First Quarter Report
Analysis
Price Target
No Data
No Data